Equities

Kobayashi Pharmaceutical Co Ltd

Kobayashi Pharmaceutical Co Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (JPY)5,952.00
  • Today's Change44.00 / 0.74%
  • Shares traded985.20k
  • 1 Year change-23.01%
  • Beta0.0778
Data delayed at least 20 minutes, as of Jul 26 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KOBAYASHI PHARMACEUTICAL CO., LTD. a drug manufacturer. The Company operates in three segments. The Domestic Household Products Manufacturing and Sales segment and Overseas Household Products Manufacturing and Sales segment offer health care, daily necessities, skin care and other products. The Mail Order segment involves in the mail order of dietary supplements, skin care products and others.

  • Revenue in JPY (TTM)176.47bn
  • Net income in JPY17.71bn
  • Incorporated1919
  • Employees3.53k
  • Location
    Kobayashi Pharmaceutical Co LtdKDX Kobayashi Doshomachi Bldg.4-4-10, Dosho-machi, Chuo-kuOSAKA-SHI 541-0045JapanJPN
  • Phone+81 662311144
  • Websitehttps://www.kobayashi.co.jp/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
4967:TYO since
announced
Transaction
value
Focus Consumer Healthcare LLCDeal completed05 Oct 202305 Oct 2023Deal completed-12.30%75.00m
Data delayed at least 20 minutes, as of Jul 26 2024 07:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Milbon Co Ltd48.93bn4.09bn108.29bn1.14k26.002.3316.982.21125.78125.781,503.701,401.820.9431.9410.7542,920,920.007.8910.079.0111.7561.3664.698.3611.332.44--0.0049.235.586.30-28.25-2.3019.1310.26
Earth Corp159.57bn3.74bn110.27bn4.79k29.341.6113.090.691169.25169.257,213.123,084.551.092.654.5733,327,900.002.793.865.917.7440.1539.752.552.540.7614--0.159857.963.94-2.65-22.65--22.660.5164
Arata Corp944.15bn10.32bn124.22bn2.89k11.591.068.310.1316297.19297.1927,273.553,252.273.1120.217.63326,356,400.003.403.197.436.889.799.971.100.99371.16152.720.259325.185.894.5925.538.3811.6718.25
Pigeon Corp94.60bn6.89bn181.57bn3.62k25.902.3115.041.9257.6257.62790.95645.990.92963.125.3326,146,210.006.8910.058.5512.4348.2148.797.419.953.35--0.0093.82-0.4846-2.05-13.49-12.210.94672.25
Noevir Holdings Co Ltd63.28bn7.60bn196.40bn1.37k25.854.0722.213.10222.45222.451,852.691,413.880.84852.466.2946,258,040.0010.368.7212.459.8867.9366.0612.2112.213.11--0.0175103.982.301.581.11-0.4348-4.224.10
PALTAC Corp1.15tn20.64bn267.25bn2.24k12.920.95919.830.232328.39328.3918,329.984,422.862.3720.775.62514,960,200.004.244.697.408.397.507.681.791.941.43--0.002423.994.332.567.200.8661-10.836.69
Pola Orbis Holdings Inc172.05bn10.05bn317.81bn4.05k30.571.8717.671.8545.3745.37776.86741.320.85431.9110.2942,524,470.005.025.375.846.1882.0882.845.886.272.91--0.0003124.314.21-6.96-15.562.8712.16-8.25
Fancl Corp110.88bn8.83bn361.73bn1.28k38.144.1728.123.2672.7672.76913.41665.821.033.018.6286,897,340.008.237.9810.379.6366.9168.587.977.002.04--0.112152.357.03-1.9777.730.4219-7.932.53
Lion Corp404.88bn16.59bn363.22bn7.55k21.831.299.190.897158.5058.501,428.21989.970.87943.576.1053,626,760.004.135.636.058.9345.3447.604.706.451.17--0.100231.013.312.88-33.34-10.609.215.39
Kobayashi Pharmaceutical Co Ltd176.47bn17.71bn464.55bn3.53k25.462.1619.222.63233.81233.812,340.202,757.180.68653.134.9049,935,770.006.898.018.5310.1855.5356.4510.0312.242.19--0.004633.194.330.70371.582.4529.678.88
Kose Corp309.83bn14.71bn604.05bn7.56k38.672.1022.941.95257.80257.805,430.204,757.500.85221.226.5840,993,780.004.32--5.56--70.42--5.06--2.70--0.0357--3.90---37.87------
Shiseido Co Ltd982.48bn9.78bn1.85tn30.54k188.722.9320.921.8824.4624.462,457.341,574.670.75231.725.9532,170,330.000.91092.911.384.3974.4473.511.213.520.7142--0.344275.17-8.84-2.33-36.41-18.75-10.635.92
Data as of Jul 26 2024. Currency figures normalised to Kobayashi Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

10.99%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 04 Jul 20242.06m2.64%
Nomura Asset Management Co., Ltd.as of 31 May 20241.96m2.52%
Norges Bank Investment Managementas of 31 Dec 2023981.24k1.26%
Nikko Asset Management Co., Ltd.as of 05 Jul 2024909.00k1.17%
Daiwa Asset Management Co. Ltd.as of 28 Jun 2024860.70k1.10%
BlackRock Fund Advisorsas of 04 Jul 2024596.40k0.76%
Mitsubishi UFJ Asset Management Co., Ltd.as of 05 Jul 2024453.30k0.58%
MFS International Singapore Pte Ltd.as of 31 May 2024348.70k0.45%
Tokio Marine Asset Management Co., Ltd.as of 24 Jul 2023210.20k0.27%
BlackRock Investment Management (UK) Ltd.as of 30 Jun 2024192.27k0.25%
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.